A meta-analysis of the comparing of the first-generation and next-generation TKIs in the treatment of NSCLC

BackgroundThe current standard approach to the treatment of patients with non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)—sensitizing mutations has been the treatment with a first-generation EGFR-TKIs. While, with resistance develope...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yongxing Li, Jianye Yang, Yufen Xu, Ming Zhang, Xiaoping Zhang, Wenyu Chen, Xiaodong Lv
Formato: Artigo
Lenguaje:Inglês
Publicado: AIMS Press 2019-06-01
Colección:Mathematical Biosciences and Engineering
Materias:
nsclc
first-generation egfr-tkis
second/third-generation egfr-tkis
meta-analysis
Acceso en línea:https://www.aimspress.com/article/10.3934/mbe.2019283?viewType=HTML
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares